Gimv NV - ESG Rating & Company Profile powered by AI
The SDG rating for Gimv NV indicates its transparency towards the United Nations Sustainable Development Goals. This analysis of Gimv NV incorporates data points from across the web and also from public disclosures by Gimv NV. This ESG rating includes 17 UN SDGs including: 'No Poverty', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'.
Gimv NV in the Investment Management & Fund Operators industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 6.7, social score of 5.7 and governance score of 5.3.
5.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Centuria Capital Ltd | 8.0 | High |
1 | Ceylon Guardian Investment Trust PLC | 8.0 | High |
182 | Aker Horizons ASA | 6.0 | High |
182 | General Bank of Greece SA | 6.0 | High |
186 | Gimv NV | 5.9 | High |
186 | CI Financial Corp | 5.9 | High |
186 | Centum Investment Company Plc | 5.9 | High |
... | ... | ... | |
650 | Zero2ipo Holdings Inc. | 0.0 | Low |
650 | advantec Beteiligungskapital AG & Co KGaA | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Gimv NV have an accelerator or VC vehicle to help deliver innovation?
Does Gimv NV disclose current and historical energy intensity?
Does Gimv NV report the average age of the workforce?
Does Gimv NV reference operational or capital allocation in relation to climate change?
Does Gimv NV disclose its ethnicity pay gap?
Does Gimv NV disclose cybersecurity risks?
Does Gimv NV offer flexible work?
Does Gimv NV have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Gimv NV disclose the number of employees in R&D functions?
Does Gimv NV conduct supply chain audits?
Does Gimv NV disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Gimv NV conduct 360 degree staff reviews?
Does Gimv NV disclose the individual responsible for D&I?
Does Gimv NV disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Gimv NV disclose current and / or historical scope 2 emissions?
Does Gimv NV disclose water use targets?
Does Gimv NV have careers partnerships with academic institutions?
Did Gimv NV have a product recall in the last two years?
Does Gimv NV disclose incidents of discrimination?
Does Gimv NV allow for Work Councils/Collective Agreements to be formed?
Has Gimv NV issued a profit warning in the past 24 months?
Does Gimv NV disclose parental leave metrics?
Does Gimv NV disclose climate scenario or pathway analysis?
Does Gimv NV disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Gimv NV disclose the pay ratio of women to men?
Does Gimv NV support suppliers with sustainability related research and development?
Does Gimv NV disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Gimv NV reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Gimv NV involved in embryonic stem cell research?
Does Gimv NV disclose GHG and Air Emissions intensity?
Does Gimv NV disclose its waste policy?
Does Gimv NV report according to TCFD requirements?
Does Gimv NV disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Gimv NV disclose energy use targets?
Does Gimv NV disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Gimv NV have a policy relating to cyber security?
Have a different question?
Potential Risks for Gimv NV
These potential risks are based on the size, segment and geographies of the company.
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to "125 million ($144.76 million). It seeks to invest between "3 million ($3.47 million) to "30 million ($34.74 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as me